Cardiol Therapeutics Inc.

CRDL | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.89

+$0.03 (+1.61%)

At close: Sep 22, 2026, 4:00 PM ET

$1.92

+$0.03 (+1.59%)

After-hours: Sep 22, 2026, 7:46 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $214.41M

Enterprise Value $270.71M

Beta 0.52

Average Volume 824.32K

Shares Outstanding (Diluted) 114.94M

Shares Change YoY 39.06%

Institutional Ownership 25.58%

Exchange NASDAQ

ISIN CA14161Y2006

Price Performance

Price Change 1M -1.1%

Price Change 3M 77.1%

Price Change 6M 73.8%

Price Change YTD 87.1%

Price Change 1Y 66.1%

Price Change 3Y 104.4%

Price Change 5Y -58.9%

1M CAGR (ann.) 31.0%

1Y CAGR (ann.) 67.6%

5Y CAGR (ann.) -12.8%

All-Time CAGR -8.7%

Valuation

PE Ratio -7.14

Forward PE N/A

PEG Ratio -0.21

Forward PEG 0.22

PS Ratio N/A

Forward PS 306.00

PB Ratio 12.29

P/FCF Ratio -12.19

P/Adj. FCF Ratio -8.30

P/OCF Ratio -12.24

EV/Sales N/A

EV/EBIT -7.33

EV/EBITDA -7.34

EV/FCF -11.14

Earnings Yield -13.8%

FCF Yield -8.1%

Adj. FCF Yield -11.8%

Financial Health

Net Cash C$27.74M

Total Debt C$116.71K

Cash & Short-Term Investments C$27.74M

Total Assets C$31.49M

Current Ratio 5.55

Quick Ratio 5.55

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt -207.68

Interest Coverage 0.00

Altman Z-Score 11.85

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -46.9%

Returns

Return on Assets -116.1%

Return on Equity -180.1%

Return on Invested Capital -148.6%

Return on Capital Employed -148.8%

Return on Tangible Assets -116.1%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -100.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 10.3%

EPS CAGR 5Y 8.9%

EPS CAGR 10Y N/A

FCF CAGR 3Y -4.4%

FCF CAGR 5Y 1.3%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 2

EPS Growth Next 3Y 65.7%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.04

EPS Growth Est (next Q) -33.3%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $8

Price Target Upside 330.1%

Cash Flow

Operating Cash Flow C$-24.24M

Free Cash Flow C$-24.3M

Adj. Free Cash Flow C$-35.69M

FCF Per Share -$0.21

OCF Per Share -$0.21

OCF/S Ratio 0.0%

Income Statement

Revenue C$0

Gross Profit C$-52.73K

Operating Income C$-39.22M

EBITDA C$-36.87M

Net Income C$-36.67M

EPS (Diluted) -$0.36

Revenue / Employee N/A

Profit / Employee $-2.04M

Employees 18